followers view all
following view all
An International Study To Improve Treatments For Muscular Dystrophy - Somanabolic Muscle Maximizer Review
Being initiated in a large international study aimed at improving the care of muscular dystrophy patients worldwide by doctors and physical therapists, and researchers at the University of Rochester Medical Center.
Symptoms begin when the boys are young; untreated, they end up in a wheelchair before they become teenagers. With today's best treatments, the disease, which affects about 28,000 boys and young men in the United States, is often fatal in the time it reaches the patient 20S 30S him or early.
Despite decades of research, Griggs calls the current treatment landscape for the disease "chaotic." Recently he has identified 29 different therapeutic used by doctors around the world. Information Resource By Somanabolic Muscle Maximizer Review
This study was designed to eliminate the new chaos. Will with at least in funding from the National Institute of Neurological Disorders and Stroke, Griggs and co-leader and investigators at 41 other institutions around the world to study the three treatments most commonly used today.
These will include the study of 300 children aged from 4 to 7 across North America and will begin recruiting for the study in the summer of 2011. It is scheduled to fund the study to reach nearly 15 million dollars.
Central feature of muscular dystrophy is muscle weakness. The appearance of the first symptoms, often seen at the age of 2 or 3, usually come when a boy has difficulty running, jumping, or climbing stairs
From there, even with treatment, the disease progresses very quickly. And often confined to a wheelchair boys at the age of 9 or 10 because of weakness in their legs; breathing muscles and the failure of the heart muscle that begins weaken significantly in the teen years. Most patients begin to receive assistance in breathing with a ventilator while they are teenagers.
|share||like 3||report||114 views|